Microfluidic tissue biopsy and immune response drug evaluation devices and systems
Abstract
This disclosure describes microfluidic tissue biopsy and immune response drug evaluation devices and systems. A microfluidic device can include an inlet channel having a first end configured to receive a fluid sample optionally containing a tissue sample. The microfluidic device can also include a tissue trapping region at the second end of the inlet channel downstream from the first end. The tissue trapping region can include one or more tissue traps configured to catch a tissue sample flowing through the inlet channel such that the fluid sample contacts the tissue trap. The microfluidic device can also include one or more channels providing an outlet.
Claims
exact text as granted — not AI-modified1 . A microfluidic device comprising: a substrate defining: an inlet channel having a first end configured to receive a fluid sample optionally containing a tissue sample; a tissue trapping region at the second end of the inlet channel downstream from the first end, the tissue trapping region including one or more tissue traps configured to catch a tissue sample flowing through the inlet channel such that the fluid sample contacts the tissue trap; and one or more channels providing an outlet.
Join the waitlist — get patent alerts
Track US2024036031A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.